Diamond sells ACRX 6.39: Sector Update: Health Care Stocks Mixed This Afternoon; Minerva Neurosciences Climbing As Jefferies, Baird Begin Coverage with H ...
ACRX, (-42.2%) Receives Complete Response Letter from the FDA seeking additional information about its Zalviso pain-management system for post-operative patients. The company expects to resubmit its New Drug Application by the end of the year. ...
32 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home